| |
 |
|
Class Information
Number: 424/423
Name: Drug, bio-affecting and body treating compositions > Preparations characterized by special physical form > Implant or insert > Surgical implant or material
Description: Subject matter in which the composition is claimed or disclosed as surgically implantable.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6368787 |
Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
Apr. 9, 2002 |
| 6368858 |
Modulation of multicellular aggregates by pressure from growth in a matrix |
Apr. 9, 2002 |
| 6365153 |
Mechanically elongated neuronal cells and methods for producing and using these cells |
Apr. 2, 2002 |
| 6365172 |
Device of bioabsorbable triglycolic acid poly(ester-amide)s, and methods of making the same |
Apr. 2, 2002 |
| 6365385 |
Methods of culturing and encapsulating pancreatic islet cells |
Apr. 2, 2002 |
| 6361780 |
Microporous drug delivery system |
Mar. 26, 2002 |
| 6361797 |
Hydrogel compositions useful for the sustained release of macromolecules and methods of making same |
Mar. 26, 2002 |
| 6358532 |
Calcium phosphate microcarriers and microspheres |
Mar. 19, 2002 |
| 6358989 |
Therapeutic inhibitor of vascular smooth muscle cells |
Mar. 19, 2002 |
| 6355275 |
Embolization using carbon coated microparticles |
Mar. 12, 2002 |
| 6355705 |
Anaesthetic bone cement |
Mar. 12, 2002 |
| 6356782 |
Subcutaneous cavity marking device and method |
Mar. 12, 2002 |
| 6352707 |
Transplant encapsulation in a hydrogel matrix to obscure immune recognition |
Mar. 5, 2002 |
| 6352708 |
Solution and method for treating autologous tissue for implant operation |
Mar. 5, 2002 |
| 6352709 |
Localized use of nitric oxide-adducts to prevent internal tissue damage |
Mar. 5, 2002 |
| 6352721 |
Combined diffusion/osmotic pumping drug delivery system |
Mar. 5, 2002 |
| 6350462 |
Hollow porous ceramic carrier for embedding in patient for sustained medicament release and method of preparation thereof |
Feb. 26, 2002 |
| 6350527 |
Gels and multilayer surface structures from boronic acid containing polymers |
Feb. 26, 2002 |
| 6344061 |
Device for incorporation and release of biologically active agents |
Feb. 5, 2002 |
| 6344488 |
Temperature-controlled pH-dependent formation of ionic polysaccharide gels |
Feb. 5, 2002 |
| 6342202 |
Compositions for use in embolizing blood vessels |
Jan. 29, 2002 |
| 6340477 |
Bone matrix composition and methods for making and using same |
Jan. 22, 2002 |
| 6335028 |
Implantable particles for urinary incontinence |
Jan. 1, 2002 |
| 6335029 |
Polymeric coatings for controlled delivery of active agents |
Jan. 1, 2002 |
| 6335384 |
Methods for embolizing blood vessels |
Jan. 1, 2002 |
| 6331309 |
Hydrogel compositions for the controlled release administration of growth factors |
Dec. 18, 2001 |
| 6331310 |
Solid dose delivery vehicle and methods of making same |
Dec. 18, 2001 |
| 6331311 |
Injectable depot gel composition and method of preparing the composition |
Dec. 18, 2001 |
| 6331312 |
Bioresorbable ceramic composites |
Dec. 18, 2001 |
| 6331313 |
Controlled-release biocompatible ocular drug delivery implant devices and methods |
Dec. 18, 2001 |
| 6331422 |
Enzyme-mediated modification of fibrin for tissue engineering |
Dec. 18, 2001 |
| 6328979 |
Sustained release medicinal compositions |
Dec. 11, 2001 |
| 6328990 |
Bioactive, degradable composite for tissue engineering |
Dec. 11, 2001 |
| 6326017 |
Methods for the localized delivery of agents to blood vessels |
Dec. 4, 2001 |
| 6326018 |
Flexible sheet of demineralized bone |
Dec. 4, 2001 |
| 6326019 |
Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries |
Dec. 4, 2001 |
| 6322804 |
Implantable biocompatible immunoisolatory vehicle for the delivery of selected therapeutic products |
Nov. 27, 2001 |
| 6322815 |
Multipart drug delivery system |
Nov. 27, 2001 |
| 6319492 |
Copolymers of tyrosine-based polyarylates and poly(alkylene oxides) |
Nov. 20, 2001 |
| 6319512 |
Implants for controlled release of pharmaceutically active principles and method for making same |
Nov. 20, 2001 |
| 6316522 |
Bioresorbable hydrogel compositions for implantable prostheses |
Nov. 13, 2001 |
| 6316018 |
Drug-releasing coatings for medical devices |
Nov. 13, 2001 |
| 6312684 |
Method of inducing resistance to tumor growth |
Nov. 6, 2001 |
| 6312707 |
Treatment of sickle cell anemia crises with fructose-1,6-diphosphate as an analgesic drug |
Nov. 6, 2001 |
| 6312708 |
Botulinum toxin implant |
Nov. 6, 2001 |
| 6309420 |
Enhanced visibility materials for implantation in hard tissue |
Oct. 30, 2001 |
| 6309635 |
Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo |
Oct. 30, 2001 |
| 6309659 |
Reverse phase connective tissue repair composition |
Oct. 30, 2001 |
| 6309669 |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix |
Oct. 30, 2001 |
| 6306418 |
Controlled expansion sphincter augmentation media |
Oct. 23, 2001 |
|
|
|
